1. Arcadia Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market

    DAVIS, Calif. (August 12, 2022) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced today that it has entered into securities purchase agreements with a single healthcare-focused institutional investor for the purchase and sale of 4,722,506 shares of its common stock (or common stock equivalents) at…Continue Reading »
  2. Arcadia Biosciences Announces Strong Second-Quarter and First-Half 2022 Financial Results and Business Highlights

    — Revenue increased 175% from Q2 2021 — GoodWheat™ pasta successfully launched in retail and online — $2M milestone achievement recognized for HB4® soybean approval in China DAVIS, Calif. (August 11, 2022) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results…Continue Reading »
  3. Arcadia Biosciences Announces Date of Second Quarter 2022 Financial Results and Business Highlights Conference Call

    DAVIS, Calif. (July 28, 2022) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the second quarter and first half of 2022 after market close on August 11, 2022. The company has scheduled a conference…Continue Reading »
  4. Arcadia Biosciences Announces First Quarter 2022 Financial Results

    –  Sales increased 48% from Q4 2021 – First retail orders of GoodWheat™ pasta shipped – HB4® soybeans approved in China, $2M milestone anticipated DAVIS, Calif. (May 12, 2022) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the…Continue Reading »
  5. Arcadia Biosciences Announces Date of First Quarter 2022 Financial Results and Business Highlights Conference Call

    DAVIS, Calif. (May 5, 2022) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the first quarter of 2022 after market close on May 12, 2022. The company has scheduled a conference call for 4:30…Continue Reading »
  6. Arcadia Biosciences Announces Fourth-Quarter and Full-Year 2021 Financial Results and Business Highlights

    – Strong balance sheet entering 2022 – – Expanded consumer product offerings in on-trend categories – – Experienced CPG talent added throughout organization – DAVIS, Calif. (March 30, 2022) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the…Continue Reading »
  7. Arcadia Biosciences Announces Date of Fourth-Quarter and Full-Year 2021 Financial Results and Business Highlights Conference Call

    DAVIS, Calif. (March 23, 2022) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its 2021 fourth-quarter and full-year financial and business results after market close on March 30, 2022. The company has scheduled a conference call for 4:30 p.m. Eastern…Continue Reading »
  8. Arcadia Biosciences Names Stan Jacot as CEO

    — Transformational change leader and CPG veteran brings 30 years of experience building high-functioning teams, driving organizational growth — DAVIS, Calif. (February 2, 2022) – Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, has appointed veteran consumer goods leader Stan Jacot as chief executive officer, effective today….Continue Reading »